Steward Partners Investment Advisory, LLC Affimed N.V. Transaction History

Steward Partners Investment Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$1.1 - $2.45 $165 - $367	-150 Reduced 23.08%	500 $0
Q2 2022 Aug 04, 2022	BUY	$2.27 - $4.86 $1,475 - $3,159	650 New	650 $2,000
Q2 2021 Aug 13, 2021	SELL	$7.78 - $11.4 $15,560 - $22,800	-2,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.12 - $8.48 $10,240 - $16,960	2,000 New	2,000 $15,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.